MESO Stock: Price, Earnings History and SEC Filings
Mesoblast Limited (MESO) last traded at $15.16, down 3.25% on the latest session and up 3.5% over the past month.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MESO earnings history
Earnings history is not available right now.
Latest SEC filings for MESO
Insider filing activity
MESO insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
MESO news
- 3 Australian Growth Stocks To Watch In October 2026Oct 30, 2026 · finance.yahoo.com
- 3 Australian Founder Led Stocks Trading Up To 59% Below Fair ValueOct 30, 2026 · finance.yahoo.com
- 3 Australian Healthcare Stocks With Revenue Up To 2bOct 29, 2026 · finance.yahoo.com
- Ryoncil Growth Could Change The Case For Mesoblast StockOct 29, 2026 · finance.yahoo.com
- Inside Biotech: Mesoblast surges 24% as Ryoncil sales climb and cash spend falls sharplyOct 29, 2026 · proactiveinvestors.com
- Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)Oct 29, 2026 · finance.yahoo.com
- Top 3 Australian Founder Led Stocks With Revenue Over A$120 MillionOct 28, 2026 · finance.yahoo.com
- Emerald Resources And 2 Australian Growth Stocks To WatchOct 23, 2026 · finance.yahoo.com
About Mesoblast Limited
Mesoblast Limited (MESO) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in Australia. Its fiscal year ends in June.